Researchers have been able to cure it in mice, and a clinical trial in human women is due to begin later this year, the New Scientist reports.
PCOS affects up to one in five women worldwide, it says.
It affects how a woman’s ovaries work – symptoms include irregular periods and difficulty getting pregnant.
“It’s by far the most common hormonal condition affecting women of reproductive age, but it hasn’t received a lot of attention,” Robert Norman at the University of Adelaide in Australia told the New Scientist.
What is PCOS?
- Irregular periods or no periods, which means ovaries don’t regularly release eggs
- Difficulty getting pregnant
- Excessive hair growth caused by excess testosterone
- Weight gain
- Oily skin and acne
- More than half of the women affected don’t have any symptoms.
Researchers at the French National Institute of Health and Medical Research (Inserm) have found that the syndrome may be triggered before birth by excess exposure in the womb to a hormone called anti-Müllerian hormone (AMH).
They found pregnant women with PCOS have 30% higher levels of the hormone than normal.
As the syndrome is known to run in families, they wanted to test the idea that the imbalance in pregnancy might induce the same condition in daughters.
They injected AMH into pregnant mice, and as the offsprings grew up, found that they had many PCOS symptoms, including infrequent ovulation and delays in falling pregnant.
The excess hormone seemed to overstimulate a set of brain cells that raises the level of testosterone.
After treatment with an IVF drug used to control women’s hormones, cetrorelix, the mice stopped showing PCOS symptoms.
“It could be an attractive strategy to restore ovulation and eventually increase the pregnancy rate in these women,” Paolo Giacobini, whose group conducted the research at Inserm, told the New Scientist.
If the syndrome is indeed passed from mothers to daughters via hormones in the womb, that could explain why it’s been so hard to pinpoint any genetic cause of the disorder
“The findings may also explain why women with the syndrome seem to get pregnant more easily in their late 30s and early 40s. Anti-Müllerian hormone levels are known to decline with age, usually signalling reduced fertility. But in women who start out with high levels, age-related declines may bring them into the normal fertility range – although this still needs to be tested,” says Robert Norman
Speaking to My Medical Mantra, Dr Niranjan Chavan, Professor at the Gynaecology department of Mumbai’s civic-run Sion hospital, said, “In PCOS patients high levels of AMH levels are observed. Studies done up till now suggest that excess AHM injections in pregnant mice have shown their offsprings to have PCOS symptoms. The excess hormone seemed to overstimulate a set of brain cells that raises the level of testosterone. Also, women having PCOS symptoms and signs have more than 30% increase in AMH levels as compared to normal. We need to do further studies on humans and evaluate it.”